Systemic mitomycin C as second-line treatment for metastatic urothelial cancer

Acta Oncol. 1995;34(7):978-9. doi: 10.3109/02841869509127221.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II

MeSH terms

  • Aged
  • Antibiotics, Antineoplastic / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Cisplatin / administration & dosage
  • Female
  • Humans
  • Male
  • Methotrexate / administration & dosage
  • Middle Aged
  • Mitomycin / administration & dosage*
  • Neoplasm Metastasis
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antibiotics, Antineoplastic
  • Mitomycin
  • Carboplatin
  • Cisplatin
  • Methotrexate